Abstract
Prader-Willi Syndrome (PWS) is an unusual and multifacted birth defect characterized by severe hypotonia, hypogenitalism, delayed development, and mental retardation (Prader et al, 1956; Zellweger and Schneider, 1968; Zellweger 1988). Hyperphagia becomes evident early in childhood and is accompanied by predisposition to increasingly unstable emotions and behavior Problems that intensify over time (Sulzbacher, 1988). If the insatiable appetite is left unmanaged, affected individuals may become morbidly obese and die of complications of obesity. A no less important component of the Syndrome is the evolution over time of inappropriate and often bizarre behaviors that escalate in frequency and intensity with age, necessitating ongoing management and Intervention (Greenswag, 1987). Anecdotal reports of chemical management of these behaviors, accompanied by conflicting opinions regarding their appropriateness and effectiveness, are emerging. No data exists to guide clinicians’ choice of medication, dosage, Potential side effects, and time frame for administration. Moreover, information comparing the effectiveness of psychotropic medications with non-drug behavioral Intervention is not available.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cassidy SB (1991) Personal communication
Greenswag LR (1987) Adults with Prader-Willi Syndrome: A survey of 232 cases. Dev Med Child Neurol 29: 145–152
Minnesota Department of Public Weifare (1980) The Use of Medications in Controlling the Behavior of the Mentally Retarded. Proceedings of the conference on the Use of Medications in Controlling the Behavior of the Mentally Retarded. Sponsored by the Department of Public Weifare, State of Minnesota, September 22–24, 1980
Prader A, Labhart A and Willi H (1956) Ein Syndrom von Adipositas, Kleinwuchs, Kryptochismus und Oligophrenie nach Myatonieartigem Zustand im Neugeborenalter. Schweiz Med Wochenschr 86: 1260-1261
Sulzbacher S (1988) Psychological and behavioral management. In: Greenswag LR and Alexander RC (eds), Management of Prader- Willi Syndrome. Springer-Verlag, New York, pp 99–122
Whitman BY and Accardo P (1987) Emotional symptoms in Prader-Willi adolescents. Am J Med Genet 4 (1): 636–638
Zellweger H and Schneider H (1968) Syndrome of hypotonia- hypomentia-hypogonadism-obesity (HHHO) or Prader-Willi Syndrome. Am J Dis Child 115: 588–598
Zellweger H (1988) Differential diagnosis in Prader-Willi Syndrome. In: Greenswag LR and Alexander RC (eds) Management of Prader-Willi Syndrome, Springer-Verlag, New York pp 15–22
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Whitman, B.Y., Greenswag, L.R. (1992). The Use of Psychotropic Medications in Persons with Prader-Willi Syndrome. In: Cassidy, S.B. (eds) Prader-Willi Syndrome. NATO ASI Series, vol 61. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84283-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-84283-2_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84285-6
Online ISBN: 978-3-642-84283-2
eBook Packages: Springer Book Archive